FINANCIAL RELEASES

Date Title View
Toggle Summary Qorvo Biotechnologies Awarded $24.4 Million National Institutes of Health Contract to Scale Point-of-Care COVID-19 Antigen Testing
Qorvo Omnia™ diagnostic test platform uses innovative radio frequency technology designed to achieve rapid and specific COVID-19 antigen results GREENSBORO, N.C., April 15, 2021 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq: QRVO), a leading provider of innovative radio frequency (RF) solutions that connect
View HTML
Toggle Summary Qorvo® Biotechnologies Receives FDA Emergency Use Authorization (EUA) for Rapid COVID-19 Antigen Testing
GREENSBORO, N.C., April 15, 2021 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq: QRVO), a leading provider of innovative radio frequency (RF) solutions that connect the world, today announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the Qorvo Omnia™
View HTML
Toggle Summary Qorvo® to Present at the Morgan Stanley Technology, Media and Telecom Conference
GREENSBORO, N.C., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, today announced that Company executives are scheduled to present at the Morgan Stanley Technology, Media and Telecom Conference on Thursday, March 4, 2021
View HTML
Toggle Summary Qorvo® to Present at the Raymond James 42nd Annual Institutional Investors Conference
GREENSBORO, N.C., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, today announced that Company executives are scheduled to present at the Raymond James 42nd Annual Institutional Investors Conference on Tuesday, March 2,
View HTML
Toggle Summary Qorvo® to Present at the Goldman Sachs 2021 Technology and Internet Conference
GREENSBORO, N.C., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, today announced that Company executives are scheduled to present at the Goldman Sachs 2021 Technology and Internet Conference on Thursday, February 11,
View HTML
Toggle Summary Qorvo® Announces Fiscal 2021 Third Quarter Financial Results
GREENSBORO, N.C., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Qorvo ® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, today announced financial results for the Company’s fiscal 2021 third quarter, ended January 2, 2021. On a GAAP basis, revenue for Qorvo’s fiscal 2021
View HTML
Toggle Summary Qorvo® to Webcast Quarterly Earnings Conference Call on February 3, 2021
GREENSBORO, N.C., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Qorvo ® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, will host a conference call to review fiscal 2021 third quarter financial results on Wednesday, February 3, 2021, at 5:00 p.m. (ET).
View HTML
Toggle Summary Qorvo® to Present at Barclays Global Technology, Media and Telecommunications Virtual Conference
GREENSBORO, N.C., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, today announced that Company executives are scheduled to present at the Barclays Global Technology, Media and Telecommunications Virtual Conference on
View HTML
Toggle Summary Qorvo® to Present at Wells Fargo TMT Virtual Summit
GREENSBORO, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq: QRVO), a leading provider of innovative RF solutions that connect the world, today announced that Company executives are scheduled to present at the Wells Fargo Tech, Media & Telecom (“TMT”) Virtual Summit on Tuesday, December 1,
View HTML
Toggle Summary Qorvo® Acquires UWB Software Provider 7Hugs Labs S.A.S.
GREENSBORO, N.C., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Qorvo ® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, has acquired Paris-based 7Hugs Labs S.A.S., a leading software provider for ultra-wideband (UWB) applications.
View HTML